Cellromax Science Co., Ltd. (KOSDAQ:471820)
5,300.00
+20.00 (0.38%)
At close: Apr 29, 2026
3.52% (1Y)
| Market Cap | 58.30B |
| Revenue (ttm) | 22.18B |
| Net Income (ttm) | 2.97B |
| Shares Out | 11.04M |
| EPS (ttm) | 261.00 |
| PE Ratio | 20.23 |
| Forward PE | n/a |
| Dividend | 185.00 (3.50%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | 21,439 |
| Average Volume | 31,220 |
| Open | 5,290.00 |
| Previous Close | 5,280.00 |
| Day's Range | 5,260.00 - 5,330.00 |
| 52-Week Range | 4,560.00 - 7,690.00 |
| Beta | n/a |
| RSI | 58.55 |
| Earnings Date | May 21, 2026 |